Search
for
Sort by
Research 571–600 of 1000+
- A Review on Ayurvedic Niadanatmak Concept of Khalityavyadhi
- 498 Efficacy of photobiomodulation therapy for the off-label treatment of alopecia in skin types V-VI
- Historical Archives
- Canine alopecia X
- The successful treatment of nephrogenic fibrosing dermopathy (NFD) with mycophenolate mofetil (MMF)
- The prevalence of itch and pain and its characteristics in patients with mild to moderate insufficiency and its relationship to the degree of venous insufficiency
- Their year at Parkland Memorial Hospital (2005)
- Evaluación endocrinológica en el acné
- Drug-Induced Skin, Nail and Hair Disorders
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Female Pattern Hair Loss and its Relationship to Permanent/Cicatricial Alopecia: A New Perspective
- Replicative stress, stem cells and aging
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Factors Associated with Severity of Alopecia Areata
- Elevated Free Testosterone Levels in Women With Acne
- Paraneoplastic alopecia associated with internal malignancies in the cat
- Skin disease in pregnancy
- Hair loss in elderly women
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Hypersensitivity Reactions to Anticoagulant Drugs
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Hormone therapy in acne
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Unruly hair
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Alopecia and Hirsuties
- Prognosis and Management of Congenital Hair Shaft Disorders without Fragility—Part II